Page last updated: 2024-10-15

3-hydroxykynurenine and Colorectal Neoplasms

3-hydroxykynurenine has been researched along with Colorectal Neoplasms in 1 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gylling, B1
Myte, R1
Schneede, J1
Hallmans, G1
Häggström, J1
Johansson, I1
Ulvik, A1
Ueland, PM1
Van Guelpen, B1
Palmqvist, R1

Other Studies

1 other study available for 3-hydroxykynurenine and Colorectal Neoplasms

ArticleYear
Vitamin B-6 and colorectal cancer risk: a prospective population-based study using 3 distinct plasma markers of vitamin B-6 status.
    The American journal of clinical nutrition, 2017, Volume: 105, Issue:4

    Topics: Adult; Aged; Biomarkers; Case-Control Studies; Colorectal Neoplasms; Female; Humans; Inflammation; K

2017